![Steve Colletti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steve Colletti
Chief Tech/Sci/R&D Officer at
Korro Bio, Inc.
Profile
Steve Colletti is currently the Chief Scientific Officer at Korro Bio, Inc. He previously worked as the SVP-Drug Discovery Research & Development at Zymergen, Inc. from 2021 to 2023.
Before that, he was the Chief Scientific Officer at Lodo Therapeutics Corp.
from 2018 to 2021.
Dr. Colletti holds a doctorate degree from Boston University and an undergraduate degree from Loyola University of Chicago.
Steve Colletti active positions
| Companies | Position | Start |
|---|---|---|
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Chief Tech/Sci/R&D Officer | 2023-01-31 |
Former positions of Steve Colletti
| Companies | Position | End |
|---|---|---|
| ZYMERGEN INC. | Corporate Officer/Principal | 2022-12-31 |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Chief Tech/Sci/R&D Officer | 2021-04-30 |
Training of Steve Colletti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
 Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymergen, Inc.
 Zymergen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that designs and develops genomics products | Health Technology |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
- Stock Market
- Insiders
- Steve Colletti
